Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab.
作者信息
Wenzel Philip, Kopp Sabrina, Göbel Sebastian, Jansen Thomas, Geyer Martin, Hahn Felix, Kreitner Karl-Friedrich, Escher Felicitas, Schultheiss Heinz-Peter, Münzel Thomas
机构信息
Center for Cardiology - Cardiology I, University Medical Center, Mainz, Germany.
German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, Mainz, Germany.
出版信息
Cardiovasc Res. 2020 Aug 1;116(10):1661-1663. doi: 10.1093/cvr/cvaa160.
Abstract
摘要
相似文献
1
Evidence of SARS-CoV-2 mRNA in endomyocardial biopsies of patients with clinically suspected myocarditis tested negative for COVID-19 in nasopharyngeal swab.
Cardiovasc Res. 2020 Aug 1;116(10):1661-1663. doi: 10.1093/cvr/cvaa160.
2
Atypical lymphocyte morphology in SARS-CoV-2 infection.
Pathol Res Pract. 2020 Sep;216(9):153063. doi: 10.1016/j.prp.2020.153063. Epub 2020 Jun 10.
3
Endomyocardial Biopsy in a Pediatric Patient With Cardiac Manifestations of COVID-19.
Circ Heart Fail. 2020 Nov;13(11):e007384. doi: 10.1161/CIRCHEARTFAILURE.120.007384. Epub 2020 Nov 12.
4
[Lymphocytic myocarditis in patients with COVID-19 (4 autopsy cases)].
Arkh Patol. 2020;82(5):57-62. doi: 10.17116/patol20208205157.
5
Myocarditis in a 16-year-old boy positive for SARS-CoV-2.
Lancet. 2020 Jun 27;395(10242):e116. doi: 10.1016/S0140-6736(20)31307-6.
6
Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging.
Circ Cardiovasc Imaging. 2020 May;13(5):e010897. doi: 10.1161/CIRCIMAGING.120.010897. Epub 2020 May 13.
7
COVID-19: Brief check through the pathologist's eye (autopsy archive).
Pathol Res Pract. 2020 Nov;216(11):153195. doi: 10.1016/j.prp.2020.153195. Epub 2020 Aug 28.
8
COVID-19-Associated Stress (Takotsubo) Cardiomyopathy.
Circ Cardiovasc Imaging. 2020 Jul;13(7):e011222. doi: 10.1161/CIRCIMAGING.120.011222. Epub 2020 Jul 15.
9
Virology, transmission, and pathogenesis of SARS-CoV-2.
BMJ. 2020 Oct 23;371:m3862. doi: 10.1136/bmj.m3862.
10
COVID-19 and lung pathology.
Indian J Pathol Microbiol. 2020 Apr-Jun;63(2):171-172. doi: 10.4103/IJPM.IJPM_280_20.
引用本文的文献
1
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease.
Front Immunol. 2025 Feb 12;15:1376654. doi: 10.3389/fimmu.2024.1376654. eCollection 2024.
2
Persistence of coronavirus in the cardiac tissue in patients following recovery from COVID-19.
Cardiovasc Diagn Ther. 2024 Aug 31;14(4):459-461. doi: 10.21037/cdt-24-333. Epub 2024 Aug 17.
3
Pediatric endocarditis - a stone left after the pandemic cascade.
Front Cell Infect Microbiol. 2024 Jul 15;14:1393315. doi: 10.3389/fcimb.2024.1393315. eCollection 2024.
4
Persistence of SARS-CoV-2 colonization and high expression of inflammatory factors in cardiac tissue 6 months after COVID-19 recovery: a prospective cohort study.
Cardiovasc Diagn Ther. 2024 Apr 30;14(2):251-263. doi: 10.21037/cdt-23-381. Epub 2024 Apr 23.
5
Oxidative Stress in Sepsis: A Focus on Cardiac Pathology.
Int J Mol Sci. 2024 Mar 2;25(5):2912. doi: 10.3390/ijms25052912.
6
Advancing Precision Medicine in Myocarditis: Current Status and Future Perspectives in Endomyocardial Biopsy-Based Diagnostics and Therapeutic Approaches.
J Clin Med. 2023 Jul 31;12(15):5050. doi: 10.3390/jcm12155050.
7
The landscape of abnormal pathway activation confers COVID-19 patients' molecular sequelae earlier than clinical phenotype.
Theranostics. 2023 Jun 12;13(10):3451-3466. doi: 10.7150/thno.83405. eCollection 2023.
8
SARS-CoV-2-Induced Myocarditis: A State-of-the-Art Review.
Viruses. 2023 Apr 2;15(4):916. doi: 10.3390/v15040916.
9
COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events.
Vaccines (Basel). 2023 Mar 28;11(4):747. doi: 10.3390/vaccines11040747.
10
How Does COVID-19 Affect the Heart?
Curr Cardiol Rep. 2023 Mar;25(3):171-184. doi: 10.1007/s11886-023-01841-6. Epub 2023 Mar 10.
本文引用的文献
1
Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.
Ann Intern Med. 2020 Aug 18;173(4):268-277. doi: 10.7326/M20-2003. Epub 2020 May 6.
2
COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options.
Cardiovasc Res. 2020 Aug 1;116(10):1666-1687. doi: 10.1093/cvr/cvaa106.
3
Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes.
Lancet. 2020 May 9;395(10235):1516. doi: 10.1016/S0140-6736(20)30912-0. Epub 2020 Apr 23.
4
Myocardial localization of coronavirus in COVID-19 cardiogenic shock.
Eur J Heart Fail. 2020 May;22(5):911-915. doi: 10.1002/ejhf.1828. Epub 2020 Apr 11.
5
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19).
JAMA Cardiol. 2020 Jul 1;5(7):811-818. doi: 10.1001/jamacardio.2020.1017.
6
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
7
Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.
Eur Heart J. 2013 Sep;34(33):2636-48, 2648a-2648d. doi: 10.1093/eurheartj/eht210. Epub 2013 Jul 3.
Zotero 插件